Travere Therapeutics Inc.

NASDAQ: TVTX · Real-Time Price · USD
20.81
0.00 (0.00%)
At close: May 01, 2025, 3:59 PM
20.70
-0.53%
After-hours: May 01, 2025, 07:37 PM EDT

Travere Therapeutics Revenue

Travere Therapeutics reported an annual revenue of $233.18M, reflecting a 60.55% growth. For the quarter ending December 31, 2024, Travere Therapeutics generated $74.79M in revenue.
Revenue (ttm)
$233.18M
Revenue Growth
60.55%
Price / Sales Ratio
5.89
Revenue / Employee
$605.65K
Employees
385
Market Cap
1.85B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 233.18M +60.55%
Dec 31, 2023 145.24M -31.50%
Dec 31, 2022 212.02M -6.80%
Dec 31, 2021 227.49M +14.71%
Dec 31, 2020 198.32M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.